Watchlist Price Alert

Talaris Therapeutics Inc. (TALS)

NASDAQ: TALS · Real-Time Price · USD

2.72

-0.02 (-0.73%)

At close: Oct 19, 2023, 8:00 PM

Talaris Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-8.93M	-16.5M	-24.08M	-19.82M	-19.82M	-18.41M	-18.41M	-14.39M	-13.06M	-11.06M	-9.01M	-6.83M	-6.14M	-4.74M	-4.97M
Interest Income	n/a	1.76M	n/a	300.00	200.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-7.01M	-14.74M	-22.5M	-18.53M	-19.01M	-18.1M	-18.26M	-14.24M	-12.94M	-11.35M	-9.3M	-6.78M	-6.42M	-4.66M	-4.85M
Net Income	-7.01M	-14.74M	-20.92M	-14.99M	-18.2M	-18.1M	-18.26M	-14.24M	-12.94M	-11.35M	-9.3M	-6.78M	-6.42M	-4.66M	-4.85M
Selling & General & Admin	9.11M	6.03M	6.18M	5.18M	4.84M	5.23M	4.22M	3.8M	3.87M	3.49M	2.54M	2.45M	2.18M	1.33M	1.44M
Research & Development	267K	4.09M	13.41M	14.64M	14.98M	13.19M	14.2M	10.59M	9.18M	7.57M	6.47M	4.38M	3.96M	3.4M	3.54M
Other Expenses	89K	6.39M	4.48M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	9.47M	10.11M	19.6M	19.82M	19.82M	18.41M	18.41M	14.39M	13.06M	11.06M	9.01M	6.83M	6.14M	4.74M	4.97M
Interest Expense	1.92M	1.76M	n/a	1.77M	812K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	9.47M	10.11M	19.6M	19.82M	19.82M	18.41M	18.41M	14.39M	13.06M	11.06M	9.01M	6.83M	6.14M	4.74M	4.97M
Income Tax Expense	n/a	4.62M	-1.58M	-3.54M	-812K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	4.27M	4.22M	4.18M	4.15M	4.14M	41.09M	40.98M	40.93M	40.67M	27.37M	41.24M	21.19M	21.19M	21.19M	21.19M
Shares Outstanding (Diluted)	4.27M	4.22M	4.18M	4.15M	4.14M	41.09M	40.98M	40.93M	40.67M	27.37M	41.24M	21.19M	21.19M	21.19M	21.19M
EPS (Basic)	-1.64	-3.49	-5	-3.61	-4.4	-0.44	-0.45	-0.35	-0.32	-0.41	-0.23	-0.32	-0.3	-0.22	-0.23
EPS (Diluted)	-1.64	-3.49	-5	-3.61	-4.4	-0.44	-0.45	-0.35	-0.32	-0.41	-0.23	-0.32	-0.3	-0.22	-0.23
EBITDA	-8.93M	-16.5M	-14.48M	1.74M	-19.25M	-17.86M	-17.93M	-14.2M	-12.89M	-10.92M	-8.87M	-6.71M	-6.01M	-4.64M	-4.88M
EBIT	-5.1M	-12.97M	n/a	-16.76M	-18.2M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	-39.59K	261K	9.6M	553K	570K	551K	488K	188K	167K	133K	135K	125K	129K	101K	92K